{"schema_version":"secwatch.filing_event.v1","accession":"0001809519-25-000021","form_type":"8-K","ticker":"GDRX","cik":"0001809519","company_name":"GoodRx Holdings, Inc.","filed_at":"2025-02-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.969062+00:00","generated_at":"2026-05-27T02:49:24.220000+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"GoodRx names Christopher McGinnis as CFO, effective Feb 4, 2025","bullets":["McGinnis was CEO of Citizens Rx; succeeds Romin Nabiey (interim CFO), who remains CAO.","Base salary of $500,000; eligible for annual cash bonus targeted at 100% of base salary.","One-time signing bonus of $250,000; must remain employed through first anniversary or repay pro-rata.","Equity awards totaling $7M: $3.5M RSU and $3.5M option; vest 25% on Feb 15, 2026 then quarterly over 4 years.","McGinnis becomes a Tier 1 participant in the Executive Severance Plan."],"urls":{"canonical":"https://secwatch.observer/filing/0001809519-25-000021","json":"https://secwatch.observer/filing/0001809519-25-000021.json","markdown":"https://secwatch.observer/filing/0001809519-25-000021.md","text":"https://secwatch.observer/filing/0001809519-25-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1809519/000180951925000021/0001809519-25-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1809519/000180951925000021/gdrx-20250204.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T02:49:24.220000+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ab07329d41","claim":"Christopher A. McGinnis was appointed as Chief Financial Officer and Treasurer at GoodRx Holdings, Inc..","evidence_excerpt":"On February 4, 2025, the Board of Directors (the “Board”) of GoodRx Holdings, Inc. (the “Company”) appointed Christopher A. McGinnis as Chief Financial Officer and Treasurer of the Company, effective as of his commencement of employment, which occurred on February 4, 2025 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1809519/000180951925000021/0001809519-25-000021-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer and Treasurer"}],"fact_type":"executive_change"},{"claim_id":"fd8da5d5f9","claim":"Romin Nabiey changed role as Chief Accounting Officer at GoodRx Holdings, Inc..","evidence_excerpt":"Mr. McGinnis succeeds Romin Nabiey who, as previously disclosed, has been serving as Interim Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1809519/000180951925000021/0001809519-25-000021-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Role","value":"Chief Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}